Search concepts
|
Selected Filters
|
- 850 - 900 out of 1,314 results
Search results
-
Neuronal Spines Tracking and Analysis for Time-Lapse 3D Optical Microscopy
7/1/07 → 6/14/13
Project: Federal Funding Agencies
-
Neuroplasticity Integrating Human Induced Neuralized Pluripotent Stem Cells (NiPSCs) in SCI Animals
1/1/17 → 12/31/19
Project: Non Profit
-
Newly Identified mechanisms of Ceftaroline Resistance in MRSA Clinical Strains
8/16/16 → 7/31/18
Project: Federal Funding Agencies
-
NICHD Maternal Fetal Medicine Units Network
Univ of Texas Hlth Sci Ctr Houston
4/1/08 → 3/31/11
Project: Federal Funding Agencies
-
-
NMDA Receptor in Psychosis: Specific Auto-Antibodies
Masdeu, J. C., Appel, S. H., Faridar, A., Nakawah, M. O. & Pascual, M. B.
11/14/16 → …
Project: Clinical Trial
-
-
Non-apoptotic functions of caspase-2 in cell division and genomic stability
5/1/18 → 4/30/23
Project: Federal Funding Agencies
-
Non-invasive spinal neuromodulation and robotic exoskeleton to recover upper limb function after SCI
Sayenko, D., Horner, P. J. & Kaldis, T.
7/31/21 → 7/30/23
Project: Non Profit
-
North American Clinical Trials Network for the treatment of Spinal Cord Injury
Christopher and Dana Reeve Foundation
7/1/05 → 12/31/15
Project: Non Profit
-
North American Clinical Trials Network for the treatment of Spinal Cord Injury
4/1/17 → 12/31/17
Project: Non Profit
-
North American Clinical Trials Network for the treatment of Spinal Cord Injury
Christopher and Dana Reeve Foundation
1/1/16 → 12/31/18
Project: Non Profit
-
-
Novel carbon nanozyme mechanisms for traumatic brain injury therapy
4/1/20 → 3/31/25
Project: Federal Funding Agencies
-
-
Novel Determinants of Streptococcus Pyogenes Virulence and Protective Immunity in the Primate Oropharynx: A Genome-wide Strategy
Musser, J. M., Nagueh, S. & Olsen, R. J.
6/1/21 → 5/31/22
Project: Federal Funding Agencies
-
Novel Methods for the Flexible Ultrasound System utilizing Augmented Reality Just-In-Time Procedural Guidance
7/1/16 → 12/9/16
Project: Federal Funding Agencies
-
Novel potential drug targets for treatment of triple negative breast cancer
10/1/19 → 9/30/22
Project: Non Profit
-
Novel potential drug targets for treatment of triple negative breast cancer
Breast Cancer Research Foundation
10/1/15 → 1/31/20
Project: Non Profit
-
Novel regulators to enhance safer iPSC derivation and differentiation to EC
Sayed, N.
7/1/13 → 4/30/15
Project: Non Profit
-
Novel role of TDP-43 in DNA strand break repair and implications to ALS
Muscular Dystrophy Association
5/1/14 → 10/31/17
Project: Non Profit
-
-
-
Novel Strategies for Intervention of Inflammatory Diseases and Cancer
7/1/04 → 6/30/23
Project: Federal Funding Agencies
-
Novel Strategies for Intervention of Inflammatory Diseases and Cancer - Research Supplement to R01-CA101795
7/1/04 → 6/30/23
Project: Federal Funding Agencies
-
Novel therapeutic approach for targeting triple negative breast cancer stem cells
Chan Soon-Shiong Inst for Adv Health
1/1/13 → 12/31/17
Project: Non Profit
-
Novel Therapeutic Strategies to Co-Target AR+ and AR-/lo Prostate Cancer Cells
6/1/19 → 5/31/24
Project: Federal Funding Agencies
-
Novel Therapeutic Strategies to Co-Target Undifferentiated Prostate Cancer (PCa) Stem Cells and Bulk PCa Cells
6/1/20 → 5/31/22
Project: Federal Funding Agencies
-
Novel Therapy for Patients with Advanced Prostate Cancer Using Codependent Tumor-Specific T-Cells Expressing IL7 and IL7R
9/30/11 → 9/29/12
Project: Federal Funding Agencies
-
-
NRG-BR004: A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
Geyer, C. E., Chang, J. C., Darcourt, J. & Niravath, P. A.
3/12/19 → 2/28/25
Project: Non Profit
-
NRG-GY018. Also PRO00022968
Zaid, T., Alaniz, A., Singh, M. & Suri, A.
11/22/19 → …
Project: Clinical Trial
-
NRG-LU005
Zhang, J., Abdelrahim, M., Bernicker, E. H., Chang, J. C., Farach, A. M., Haque, W. M., Heyne, K., Morgan, P. B., Niravath, P. A. & Singh, M.
Project: Clinical Trial
-
-
NSABP B47-A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer
Niravath, P. A., Chang, J. C., Darcourt, J. & Singh, M.
Project: Clinical Trial
-
-
NY-ESO-1-specific TCR-engineered T cell immunotherapy for triple negative breast cancer
9/30/16 → 10/28/19
Project: Federal Funding Agencies
-
NY-ESO-1-specific TCR-Engineered T cell Immunotherapy for Triple Negative Breast Cancer
9/30/16 → 9/29/23
Project: Federal Funding Agencies
-
Ocrelizumab for Psychosis by Autoimmunity (OPA)
Masdeu, J. C., Faridar, A., Nakawah, M. O., Pascual, M. B. & Weinstein, B.
2/20/20 → …
Project: Clinical Trial
-
OCS Liver Perfusion (OLP) Post-Approval Registry Protocol
Hobeika, M. J., Ghobrial, R. M. & Mobley, C. M.
Project: Clinical Trial
-
OCS Liver PROTECT CAP Trial
Saharia, A., Ghobrial, R. M., Hobeika, M. J., Mobley, C. M. & Victor, III, D. W.
Project: Clinical Trial
-
OCS Lung - EXPAND II
Gaber, A. O., Chan, E. Y., Goodarzi, A., Knight, R. J. & Saharia, A.
Project: Clinical Trial
-